ReviewAnti-cancer drugs2017

A survey of renal impairment pharmacokinetic studies for new oncology drug approvals in the USA from 2010 to early 2015: a focus on development strategies and future directions.

Jim J Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.